Extreme weather once again led to lost surgery days; the Glaukos iStent continued to boost the glaucoma market.
Tilganga Institute of Ophthalmology is repurposed to provide disaster relief.
21.6 percent of patients who were offered a discount took advantage of the option in Q1-2015, according to survey respondents.
By 2020, the revenue share for these lenses is likely to grow to more than a third of total IOL revenues.
Investigators are looking into whether medical privacy rules played a role in crash that killed 150.
Eleven Biotherapeutics is latest firm to see drug candidate falter in Phase III development.
Nine other states are considering similar action.
Off-label ophthalmic use of Avastin likely would end if the agency goes forward with language proposed in draft guidance.
Shareholders approved the name change June 5.
You are not currently logged in.
©2018 Market Scope
Lost your Password